Stay updated on RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision tag v3.7.0 was added to the record history, replacing the previous v3.6.6 entry. This reflects an update to the page's history-tracking version.SummaryDifference0.1%

- Check44 days agoChange DetectedA new site revision entry (v3.6.6) was added to the history and the previous revision (v3.6.5) was removed, indicating a software release update to the page rather than changes to trial data or visible content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe record history now shows Revision: v3.6.5 replacing the previous Revision: v3.6.4. This update reflects a new page release being tracked in the history log.SummaryDifference0.1%

- Check80 days agoChange DetectedThe history now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new revision entry in the study record history.SummaryDifference0.1%

- Check101 days agoChange DetectedVersion 22 of the study record was released, updating the Study Status to Completed and the Recruitment Status to No longer recruiting, with a revision note of v3.6.3. It also reflects the removal of the previous Active, not recruiting status.SummaryDifference0.6%

Stay in the know with updates to RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.